APGE Operating Cash Flow (Statement)
Apogee Therapeutics Inc · Operating Cash Flow (Statement)
APGE Operating Cash Flow (Statement)
Latest reported-$243.89Mperiod ending
APGE TTM Cash from Operations (-$16.43M → -$243.89M)
TTM operating cash flow (statement)
High-resolution chart · PNG
APGE operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -243,894,000 | |
| -234,543,000 | |
| -227,450,000 | |
| -232,475,000 | |
| -220,744,000 | |
| -188,015,000 | |
| -171,174,000 | |
| -133,214,000 | |
| -110,570,000 | |
| -95,840,000 | |
| -74,761,000 | |
| -54,196,000 | |
| -41,554,000 | |
| -26,984,000 | |
| -16,427,000 |